PVIVAX

Knowledge sharing for relapsing malaria

Search

  • P. vivax
    • Malaria and P. vivax malaria
    • Symptoms & severity
    • Illness and mortality
    • Populations at risk
      • Pregnant women and children
      • Migratory populations
    • Role in malaria elimination
    • Lifecycle
    • Relapses
    • Vectors
  • Diagnosis & treatment
    • Diagnostic methods
      • Microscopy
      • Rapid diagnostic tests
      • Molecular methods & serology
    • Diagnosing severe vivax malaria
    • Treatment
      • Radical cure
      • Blood stage treatment
      • Liver stage treatment
    • G6PD Deficiency
      • G6PD Global Prevalence
      • G6PD diagnostics
      • Types of G6PD clinical diagnostic tests
  • Regions & countries
    • Africa
    • Eastern Mediterranean
    • South East Asia
    • The Americas
    • Western Pacific
  • In the field
  • Tools
  • Resources
  • News & events
  • About us
Photo: Daniel Schumann/MMV

About the P. vivax information hub 

Find out more
Photo: Daniel Schumann/MMV
Photo: Jaya Banerji/MMV

Tafenoquine featured this year as a key innovation in a UHC special report.

Find out more
Photo: Jaya Banerji/MMV
Photo: Schumann/MMV

Video on life-changing treatment to cure relapsing P. vivax malaria.

Find out more
Photo: Schumann/MMV
Photo: MMV

The Malaria in Pregnancy (MiP) Library now available on WWARN. 

Find out more
Photo: MMV

Featured resources

Photo: Anna Wang/MMV

Nepal

About 8.5 million people are at risk of malaria in Nepal. Despite this progress, there was a 20% increase from 2016 to 2017.
07 Oct 2019

Prevalence and distribution of G6PD deficiency: implication for primaquine use in Ethiopia

In this study, the prevalence and distribution of G6PD mutations were investigated across Ethiopia with the goal to provide additional information relevant to the use of primaquine in malaria treatment.

Malaria Journal
Peer-reviewed article
Photo: Devine and Menzie

Cost-effectiveness tool for G6PD RDTs (primaquine)

This tool assesses the cost-effectiveness of using G6PD RDTs prior to the administration of primaquine.

Vivax after falciparum study group

The vivax after falciparum Study Group was formed in March 2018, with an invitation to interested researchers with relevant data sets.
1

News

Photo: Schumann/MMV

PATH is looking for a Market Access Officer

27 Jan 2020
Photo: Damien Schumann/MMV

Request for Proposal - Development of low dose primaquine tablets in a child-friendly formulation

08 Jan 2020
Photo: Anna Wang/MMV

World Malaria report 2019 launched

04 Dec 2019
Photo: MMV

Country leaders pledge to boost malaria innovation and access to new and existing antimalarials

11 Nov 2019
View news and events
1

Events

Photo: MMV
25
Mar
2020

Call expressions of interest for membership on the Scientific and Technical Advisory Committee (STAC)

TDR invites expressions of interest for membership on its Scientific and Technical Advisory Committee (STAC). 

Deadline 30th May 2020
30
Mar
2020

Superbugs and Superdrugs

30 - 31 March 2020
London, UK
07
Apr
2020

World Health Day

7th April 2020
18
Apr
2020

11th Annual CUGH Conference (Global health in a time of political change)

18 - 20 April 2020
Washington, DC
1

Publications

16 Dec 2020

Immunity against sexual stage P. falciparum and P. vivax parasites

With the increased interest in malaria elimination, TBV and monoclonal antibodies have moved to the center stage of malaria vaccine development. Methodologies to prioritize and evaluate products are urgently needed.

Immunol Rev.
Peer-reviewed article
18 Mar 2020

Re-introduction of vivax malaria in a temperate area (Moscow region, Russia): a geographic investigation

This recent event of large-scale re-introduction of vivax malaria in a temperate area, Russia, can serve as a case study for further research.

Malaria Journal
Peer-reviewed article
16 Mar 2020

The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination.

This study in Cabo Verde determined the G6PDd prevalence in the population, relatively low compared to other African countries. Further studies are needed to characterize and genotyping the G6PD variants in the country.

PLOS One
Peer-reviewed article
16 Mar 2020

Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic

Africa needs to be prepared to deal with COVID-19, given the infectious potential of the disease and its capacity to undermine malaria control efforts. In addition to the shared vigilance that countries around the world should maintain, regions need to consider their local malaria epidemic and take additional measures for preparation.

The Lancet
Peer-reviewed article
View all publications

Get in touch

Contact us.

Submit information

Subscribe

Follow us

  • Twitter
  • LinkedIn
  • Facebook
  • Disclaimer
  • Privacy policy
A Remora website by Manta Ray Media